Are Endothelial Cell-Derived Microparticles Predictive Biomarkers in Cardiovascular Diseases?Alexander E Berezin*
Internal Medicine Department, State Medical University, Mayakovsky av, Zaporozhye, Ukraine
- *Corresponding Author:
- Alexander E Berezin
Professor, MD, PhD, Consultant of Cardiology
Unit Internal Medicine Department, State Medical
University Mayakovsky av, Zaporozhye, Ukraine
E-mail: [email protected]
Received Date: September 14, 2015 Accepted Date:: May 16,2016; Published Date: May 23, 2016
Citation: Berezin (2016) Are Endothelial Cell-Derived Microparticles Predictive Biomarkers in Cardiovascular Diseases?. Atheroscler open access 1:e101. doi: 10.4172/asoa.1000e101
Copyright: © 2016 Berezin AE. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Endothelial dysfunction is involved in the various stages of cardiovascular (CV) disease development. Microparticles (MPs) originated from endothelial cells as biological markers of endothelial injury and repair could appear sufficient predictor of clinical outcomes and probable they might use in biomarker-guided therapy. Apoptotic endothelial cell-derived MPs are able to directly mediate a microvascular inflammation and worsening of endothelial integrity. In contrast, endothelial MPs originated from activated endothelial cells might contribute vascular repair and vasodilatation. It has been suggested that endothelial cells release phenotypically and quantitatively distinct endothelial MPs in activation and apoptosis, and that the phenotype of MP pattern can provide useful information reflecting the nature of endothelial injury. Editorial comment is discussed the role of impaired immune pattern of circulating endothelial cell-derived MPs as a personalized marker of vascular remodelling or endothelial dysfunction among CV disease persons.